Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...

In 2025, CRISPR advanced gene editing with safe, effective therapies and AI tools, marking a shift towards real-world ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

CRISPR became big in 2025, bringing advances for serious Indian health risks, which will continue in the coming year ...

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...

In one of the rockiest years yet for science, Philadelphia-area researchers still managed to celebrate many wins. Here are five of them.

Explore 2025's groundbreaking scientific discoveries: the MoM-z14 galaxy, personalised CRISPR therapy, regenerative medicine, ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

CRISPR Therapeutics (NASDAQ:CRSP) is one of the best emerging technology stocks to invest in. On December 22, CRISPR Therapeutics released a comprehensive clinical update on zugocaptagene geleucel ...

These positive stories—from drops in crime to progress with climate—help us look to the next year with some degree of hope.

Vertex Pharmaceuticals (VRTX) is a top biotech pick, with strong earnings, diverse pipelines, and growth prospects. See here ...

Advances delivered what may feel like medical miracles, including the first bladder transplant, a lifesaving personalized ...